{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["9"],"submitter":["Chiapponi C"],"pubmed_abstract":["<h4>Purpose</h4>It is not mandatory to report lymphatic vessel invasion in pathology reports of papillary thyroid cancer (PTC) according to the current Union for International Cancer Control (UICC) TNM (tumor, nodes, and metastases) classification. However, there is some evidence for its correlation with lymph node metastasis (LNM) and prognosis. The aim of this study was to explore the clinical implication of lymphatic vessel invasion documentation of PTC because pathology reports play a pivotal role in postsurgical clinical decision-making in endocrine tumor boards.<h4>Methods</h4>Patients undergoing postoperative radioiodine treatment for PTC at the University Hospital of Cologne, Germany between December 2015 and March 2020 were identified. Pathology reports were screened for documenta"],"journal":["Frontiers in medicine"],"pagination":["841550"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8899077"],"repository":["biostudies-literature"],"pubmed_title":["Lymphatic Vessel Invasion in Routine Pathology Reports of Papillary Thyroid Cancer."],"pmcid":["PMC8899077"],"pubmed_authors":["Bruns CJ","Schmidt M","Alakus H","Faust M","Buttner R","Eich ML","Chiapponi C","Schultheis AM"],"additional_accession":[]},"is_claimable":false,"name":"Lymphatic Vessel Invasion in Routine Pathology Reports of Papillary Thyroid Cancer.","description":"<h4>Purpose</h4>It is not mandatory to report lymphatic vessel invasion in pathology reports of papillary thyroid cancer (PTC) according to the current Union for International Cancer Control (UICC) TNM (tumor, nodes, and metastases) classification. However, there is some evidence for its correlation with lymph node metastasis (LNM) and prognosis. The aim of this study was to explore the clinical implication of lymphatic vessel invasion documentation of PTC because pathology reports play a pivotal role in postsurgical clinical decision-making in endocrine tumor boards.<h4>Methods</h4>Patients undergoing postoperative radioiodine treatment for PTC at the University Hospital of Cologne, Germany between December 2015 and March 2020 were identified. Pathology reports were screened for documenta","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-25T22:32:50.48Z","creation":"2025-04-06T09:04:58.573Z"},"accession":"S-EPMC8899077","cross_references":{"pubmed":["35265646"],"doi":["10.3389/fmed.2022.841550"]}}